Adiponectin gene polymorphism (G276T) is not associated with incipient diabetic nephropathy in Japanese type 2 diabetic patients

Metabolism: Clinical and Experimental

Volumn 53, Issue 9, 2004, Pages 1223-1226

  Yoshioka, Keiji ^a   Yoshida, Toshihide ^b   Umekawa, Tsunekazu ^b   Kogure, Akinori ^b   Takakura, Yasuto ^b   Toda, Hitoshi ^c   Yoshikawa, Toshikazu ^b  

^a MATSUSHITA MEMORIAL HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c Sakazaki Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALBUMIN; CHOLESTEROL; CREATININE; HEMOGLOBIN; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE DURATION; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENOTYPE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADIPONECTIN; ALBUMINURIA; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DNA; DNA PRIMERS; FEMALE; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 4344693202     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.03.021     Document Type: Article

References (22)

1. Merta M., Reiterova J., Rysava R., et al. Genetics of diabetic nephropathy. Nephrol Dial Transplant. 18:(suppl 5):2003;v24-v25
2. Family Investigation of Nephropathy and Diabetes Research Group. Genetic determinants of diabetic nephropathy The Family Investigation of Nephropathy and Diabetes (FIND). J Am Soc Nephrol. 14:(suppl 2):2003;S202-S204
3. Suzuki M., Kanazawa A., Shiba M., et al. Insulin resistance in diabetic microangiopathies. J Diabetes Complications. 14:2000;40-45
4. Isomaa B., Henriscosson M., Almgren P., et al. The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia. 44:2001;1148-1154
5. Deeb S.S., Fajas L., Nemoto M., et al. A Pro12Ala substitution in PPAR gamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 20:1998;284-287
6. Hermann S.M., Ringel J., Wang J.G., et al. Peroxisome proliferator-activated receptor-2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes The Berlin Diabetes Mellitus (BeDiaM) study. Diabetes. 51:2002;2653-2657
7. Stefan N., Stumvoll M. Adiponectin - Its role in metabolism and beyond. Horm Metab Res. 34:2002;469-474
8. Hara K., Boutin P., Mori Y., et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes. 51:2002;536-540
9. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 26:(suppl 1):2003;S5-S20
10. Hirose H., Kawai T., Yamamoto Y., et al. Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes. Metabolism. 51:2002;314-317
11. Taniguchi A., Fukushima M., Sakai M., et al. Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care. 23:2000;1766-1769
12. Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med. 347:2002;1916-1923
13. Imperatore G., Hanson R.L., Pettitt D.J., et al. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Diabetes. 47:1998;821-830
14. Imano E., Kanda T., Nakatani Y., et al. Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy. Diabetes Care. 21:1998;2135-2139
15. Nakamura T., Ushiyama C., Suzuki S., et al. Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in type 2 diabetic patients with microoalbuminuria or macroalbuminuria. Diabet Med. 18:2001;308-313
16. Yu G.J., Javorschi S., Hevener A.L., et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes. 51:2002;2968-2974
17. Tsunekawa T., Hayashi T., Suzuki Y., et al. Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects. Diabetes Care. 26:2003;285-289
18. Yoshioka k., Yoshida T., Yoshikawa T. Glimepride and serum adiponectin level in type 2 diabteic subjects. Diabetes Care. 26:2003;3360-3361. (letter)
19. Looker H., Funahashi T., Krakoff J., et al. Relationship between serum adiponectin levels and measures of renal function in type 2 diabetes. Diabetes. 52:2003;A41. (suppl 1, abstr)
20. Yamamoto Y., Hirose H., Miyashita K., et al. PPAR γ2 gene Pro12Ala polymorphism may influence serum level of an adipocytes-derived protein, adiponectin, in the Japanese population. Metabolism. 51:2002;1407-1409
21. Caramori M.L., Canani L.H., Costa L.A., et al. The human peroxisome proliferator-activated receptor γ2 (PPAR γ2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes. Diabetes. 52:2003;3010-3013
22. Yoshioka K, Yoshida T, Takakura Y,, et al. Adiponectin gene polymorphism (G276T) and diabetic retinopathy in Japanese patients with type 2 diabetes. Diabet Med (in press)